Bayer CEO says company stands behind glyphosate
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-02-11 10:00 GMT | Update On 2024-03-22 09:11 GMT
Frankfurt: Bayer's CEO has said that the healthcare and crop chemicals group continues to firmly back its glyphosate weedkiller even after a recent courtroom loss in U.S. litigation over an alleged carcinogenic effect.When asked whether Bayer would alter its legal strategy, CEO Bill Anderson said in a media call that glyphosate is approved and deemed safe by regulators in every...
Login or Register to read the full article
Frankfurt: Bayer's CEO has said that the healthcare and crop chemicals group continues to firmly back its glyphosate weedkiller even after a recent courtroom loss in U.S. litigation over an alleged carcinogenic effect.
When asked whether Bayer would alter its legal strategy, CEO Bill Anderson said in a media call that glyphosate is approved and deemed safe by regulators in every major jurisdiction.
"We stand firmly behind the product and that assessment," said Anderson.
Bayer was last month ordered to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to glyphosate, though the amount of damages is expected to be reduced on appeal.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd